{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:50:47Z","timestamp":1790646647068,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Research Foundation of Korea (NRF) grant funded by the Korea government","award":["RS-2023-00251022"],"award-info":[{"award-number":["RS-2023-00251022"]}]},{"name":"Phase III (Postdoctoral fellowship) grant of the SPST (SNU-SNUH Physician Scientist Training) Program"},{"name":"SNUH Research Fund","award":["04-2024-0600"],"award-info":[{"award-number":["04-2024-0600"]}]},{"name":"Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) grant funded by the Ministry of Health&Welfare","award":["RS-2024-00439549"],"award-info":[{"award-number":["RS-2024-00439549"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47185-3","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:36:10Z","timestamp":1775230570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor habitat analysis using multiparametric MRI as a noninvasive correlate of longitudinal changes in telomerase activity in recurrent IDH-wildtype glioblastoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Seong Yun","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhyeok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunseo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minseo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Jong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongwon","family":"Pae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hye","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Kee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Sung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"47185_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-oncology 23, 1231\u20131251 (2021).","journal-title":"Neuro-oncology"},{"key":"47185_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom, Q. T. et al. The epidemiology of glioma in adults: A \u201cstate of the science\u201d review. Neuro Oncol. 16, 896\u2013913 (2014).","journal-title":"Neuro Oncol."},{"key":"47185_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987\u2013996 (2005).","journal-title":"N. Engl. J. Med."},{"key":"47185_CR4","first-page":"299","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan, A. C. et al. Management of glioblastoma: State of the art and future directions. CA Cancer J. Clin. 70, 299\u2013312 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"47185_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1775-1","volume":"576","author":"FP Barthel","year":"2019","unstructured":"Barthel, F. P. et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature 576, 112\u2013120 (2019).","journal-title":"Nature"},{"key":"47185_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell 32, 42-56. e46 (2017).","journal-title":"Cancer Cell"},{"key":"47185_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.1239947","volume":"343","author":"BE Johnson","year":"2014","unstructured":"Johnson, B. E. et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189\u2013193 (2014).","journal-title":"Science"},{"key":"47185_CR8","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/neuonc\/noae016","volume":"26","author":"MS Waitkus","year":"2024","unstructured":"Waitkus, M. S., Erman, E. N., Reitman, Z. J. & Ashley, D. M. Mechanisms of telomere maintenance and associated therapeutic vulnerabilities in malignant gliomas. Neuro-oncology 26, 1012\u20131024 (2024).","journal-title":"Neuro-oncology"},{"key":"47185_CR9","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1093\/neuonc\/noab203","volume":"23","author":"E Aquilanti","year":"2021","unstructured":"Aquilanti, E., Kageler, L., Wen, P. Y. & Meyerson, M. Telomerase as a therapeutic target in glioblastoma. Neuro Oncol. 23, 2004\u20132013 (2021).","journal-title":"Neuro Oncol."},{"key":"47185_CR10","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/med.21674","volume":"40","author":"S Bajaj","year":"2020","unstructured":"Bajaj, S., Kumar, M. S., Peters, G. & Mayur, Y. Targeting telomerase for its advent in cancer therapeutics. Med. Res. Rev. 40, 1871\u20131919 (2020).","journal-title":"Med. Res. Rev."},{"key":"47185_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030808","volume":"14","author":"NJ Robinson","year":"2022","unstructured":"Robinson, N. J. & Schiemann, W. P. Telomerase in cancer: Function, regulation, and clinical translation. Cancers 14, 808 (2022).","journal-title":"Cancers"},{"key":"47185_CR12","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/neuonc\/noad024","volume":"25","author":"E Aquilanti","year":"2023","unstructured":"Aquilanti, E. et al. Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume. Neuro-Oncol. 25, 1275\u20131285 (2023).","journal-title":"Neuro-Oncol."},{"key":"47185_CR13","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1038\/s41388-020-01405-w","volume":"39","author":"AN Guterres","year":"2020","unstructured":"Guterres, A. N. & Villanueva, J. Targeting telomerase for cancer therapy. Oncogene 39, 5811\u20135824 (2020).","journal-title":"Oncogene"},{"key":"47185_CR14","first-page":"1439","volume":"39","author":"C Suh","year":"2018","unstructured":"Suh, C., Kim, H., Jung, S., Choi, C. & Kim, S. Clinically relevant imaging features for MGMT promoter methylation in multiple glioblastoma studies: A systematic review and meta-analysis. Am. J. Neuroradiol. 39, 1439\u20131445 (2018).","journal-title":"Am. J. Neuroradiol."},{"key":"47185_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.diii.2019.02.010","volume":"100","author":"K Yamashita","year":"2019","unstructured":"Yamashita, K. et al. Predicting TERT promoter mutation using MR images in patients with wild-type IDH1 glioblastoma. Diagn. Interv. Imaging 100, 411\u2013419 (2019).","journal-title":"Diagn. Interv. Imaging"},{"key":"47185_CR16","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.3390\/cancers15061894","volume":"15","author":"S Cepeda","year":"2023","unstructured":"Cepeda, S. et al. Predicting regions of local recurrence in glioblastomas using voxel-based radiomic features of multiparametric postoperative MRI. Cancers 15, 1894 (2023).","journal-title":"Cancers"},{"key":"47185_CR17","doi-asserted-by":"publisher","first-page":"vdab051","DOI":"10.1093\/noajnl\/vdab051","volume":"3","author":"S Kihira","year":"2021","unstructured":"Kihira, S. et al. Multiparametric MRI texture analysis in prediction of glioma biomarker status: added value of MR diffusion. Neuro-Oncol. Adv. 3, vdab051 (2021).","journal-title":"Neuro-Oncol. Adv."},{"key":"47185_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1158\/1078-0432.CCR-20-2156","volume":"27","author":"JE Park","year":"2021","unstructured":"Park, J. E. et al. Spatiotemporal heterogeneity in multiparametric physiologic MRI is associated with patient outcomes in IDH-wildtype glioblastoma. Clin. Cancer Res. 27, 237\u2013245 (2021).","journal-title":"Clin. Cancer Res."},{"key":"47185_CR19","doi-asserted-by":"publisher","first-page":"8693","DOI":"10.1093\/nar\/gkw549","volume":"44","author":"N Liu","year":"2016","unstructured":"Liu, N. et al. hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor. Nucleic Acids Res. 44, 8693\u20138703 (2016).","journal-title":"Nucleic Acids Res."},{"key":"47185_CR20","first-page":"3750","volume":"63","author":"ML Falchetti","year":"2003","unstructured":"Falchetti, M. L. et al. Glioblastoma induces vascular endothelial cells to express telomerase in vitro. Cancer Res. 63, 3750\u20133754 (2003).","journal-title":"Cancer Res."},{"key":"47185_CR21","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen, P. Y. et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J. Clin. Oncol. 28, 1963\u20131972 (2010).","journal-title":"J. Clin. Oncol."},{"key":"47185_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-017-0465-1","volume":"5","author":"Y Lee","year":"2017","unstructured":"Lee, Y. et al. The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas. Acta Neuropathol. Commun. 5, 1\u201311 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"47185_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01095-x","volume":"14","author":"S Kim","year":"2022","unstructured":"Kim, S. et al. The telomere maintenance mechanism spectrum and its dynamics in gliomas. Genome Med. 14, 88 (2022).","journal-title":"Genome Med."},{"key":"47185_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/neuonc\/noad202","volume":"26","author":"JO Lee","year":"2024","unstructured":"Lee, J. O. et al. Added prognostic value of 3D deep learning-derived features from preoperative MRI for adult-type diffuse gliomas. Neuro-oncology 26, 571\u2013580 (2024).","journal-title":"Neuro-oncology"},{"key":"47185_CR25","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/jcbfm.2011.52","volume":"31","author":"A Bjornerud","year":"2011","unstructured":"Bjornerud, A., Sorensen, A. G., Mouridsen, K. & Emblem, K. E. T1-and T* 2-dominant extravasation correction in DSC-MRI: part I\u2014theoretical considerations and implications for assessment of tumor hemodynamic properties. J. Cereb. Blood Flow Metab. 31, 2041\u20132053 (2011).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"47185_CR26","doi-asserted-by":"publisher","first-page":"119474","DOI":"10.1016\/j.neuroimage.2022.119474","volume":"260","author":"A Hoopes","year":"2022","unstructured":"Hoopes, A., Mora, J. S., Dalca, A. V., Fischl, B. & Hoffmann, M. SynthStrip: skull-stripping for any brain image. Neuroimage 260, 119474 (2022).","journal-title":"Neuroimage"},{"key":"47185_CR27","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1200\/JCO.23.01059","volume":"41","author":"PY Wen","year":"2023","unstructured":"Wen, P. Y. et al. RANO 2.0: update to the response assessment in neuro-oncology criteria for high-and low-grade gliomas in adults. J. Clin. Oncol. 41, 5187\u20135199 (2023).","journal-title":"J. Clin. Oncol."},{"key":"47185_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1109\/42.906424","volume":"20","author":"Y Zhang","year":"2001","unstructured":"Zhang, Y., Brady, M. & Smith, S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 20, 45\u201357 (2001).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"47185_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nicl.2014.08.008","volume":"6","author":"RT Shinohara","year":"2014","unstructured":"Shinohara, R. T. et al. Statistical normalization techniques for magnetic resonance imaging. Neuroimage Clin. 6, 9\u201319 (2014).","journal-title":"Neuroimage Clin."},{"key":"47185_CR30","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1148\/radiol.2473070571","volume":"247","author":"KE Emblem","year":"2008","unstructured":"Emblem, K. E. et al. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 247, 808\u2013817 (2008).","journal-title":"Radiology"},{"key":"47185_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1148\/radiol.2492071659","volume":"249","author":"ES Paulson","year":"2008","unstructured":"Paulson, E. S. & Schmainda, K. M. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: Recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 249, 601\u2013613 (2008).","journal-title":"Radiology"},{"key":"47185_CR32","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1148\/rg.2021210037","volume":"41","author":"JD Shur","year":"2021","unstructured":"Shur, J. D. et al. Radiomics in oncology: A practical guide. Radiographics 41, 1717\u20131732 (2021).","journal-title":"Radiographics"},{"key":"47185_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69298-z","volume":"10","author":"A Carr\u00e9","year":"2020","unstructured":"Carr\u00e9, A. et al. Standardization of brain MR images across machines and protocols: Bridging the gap for MRI-based radiomics. Sci. Rep. 10, 12340 (2020).","journal-title":"Sci. Rep."},{"key":"47185_CR34","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/jmri.23600","volume":"35","author":"BM Ellingson","year":"2012","unstructured":"Ellingson, B. M. et al. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas. J. Magn. Reson. Imaging 35, 1472\u20131477 (2012).","journal-title":"J. Magn. Reson. Imaging"},{"key":"47185_CR35","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: Machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"47185_CR36","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","volume":"23","author":"SM Smith","year":"2004","unstructured":"Smith, S. M. et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23, S208\u2013S219 (2004).","journal-title":"Neuroimage"},{"key":"47185_CR37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJ Van Griethuysen","year":"2017","unstructured":"Van Griethuysen, J. J. et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 77, e104-e107 (2017).","journal-title":"Cancer Res."},{"key":"47185_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89218-z","volume":"11","author":"KY Shim","year":"2021","unstructured":"Shim, K. Y. et al. Radiomics-based neural network predicts recurrence patterns in glioblastoma using dynamic susceptibility contrast-enhanced MRI. Sci. Rep. 11, 9974 (2021).","journal-title":"Sci. Rep."},{"key":"47185_CR39","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1148\/radiol.09090663","volume":"254","author":"RF Barajas","year":"2010","unstructured":"Barajas, R. F. Jr. et al. Glioblastoma multiforme regional genetic and cellular expression patterns: Influence on anatomic and physiologic MR imaging. Radiology 254, 564\u2013576 (2010).","journal-title":"Radiology"},{"key":"47185_CR40","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/neuonc\/nov119","volume":"17","author":"J-M Lem\u00e9e","year":"2015","unstructured":"Lem\u00e9e, J.-M., Clavreul, A. & Menei, P. Intratumoral heterogeneity in glioblastoma: Don\u2019t forget the peritumoral brain zone. Neuro-oncology 17, 1322\u20131332 (2015).","journal-title":"Neuro-oncology"},{"key":"47185_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/sj.onc.1209011","volume":"25","author":"C Anderson","year":"2006","unstructured":"Anderson, C., Hoare, S., Ashcroft, M., Bilsland, A. & Keith, W. Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms. Oncogene 25, 61\u201369 (2006).","journal-title":"Oncogene"},{"key":"47185_CR42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF03325250","volume":"24","author":"J-Z Guan","year":"2012","unstructured":"Guan, J.-Z., Guan, W.-P., Maeda, T. & Makino, N. Different levels of hypoxia regulate telomere length and telomerase activity. Aging Clin. Exp. Res. 24, 213\u2013217 (2012).","journal-title":"Aging Clin. Exp. Res."},{"key":"47185_CR43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cancers6010226","volume":"6","author":"M-d-M Inda","year":"2014","unstructured":"Inda, M.-d-M., Bonavia, R. & Seoane, J. Glioblastoma multiforme: A look inside its heterogeneous nature. Cancers 6, 226\u2013239 (2014).","journal-title":"Cancers"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47185-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47185-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47185-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:03:17Z","timestamp":1779667397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47185-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47185"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47185-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants provided written informed consent prior to their participation in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"16051"}}